Patricia Esteban
Overview
Explore the profile of Patricia Esteban including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Flores E, Martinez-Racaj L, Blasco A, Diaz E, Esteban P, Lopez-Garrigos M, et al.
Comput Struct Biotechnol J
. 2024 Sep;
24:533-541.
PMID: 39220685
Objectives: Urinary tract infections (UTIs) are common infections within the Emergency Department (ED), causing increased laboratory workloads and unnecessary antibiotics prescriptions. The aim of this study was to improve UTI...
2.
Sesma A, Pardo J, Isla D, M Galvez E, Gascon-Ruiz M, Martinez-Lostao L, et al.
Cancers (Basel)
. 2024 Aug;
16(16).
PMID: 39199571
The development of immune checkpoint inhibitors (ICIs) has changed the therapeutic paradigm of lung cancer (LC), becoming the standard of treatment for previously untreated advanced non-small cell lung cancer (NSCLC)...
3.
Zapata-Garcia M, Moratiel-Pellitero A, Isla D, Galvez E, Gascon-Ruiz M, Sesma A, et al.
Heliyon
. 2024 Jul;
10(13):e33684.
PMID: 39050456
Lung cancer is a leading cause of morbidity and mortality globally, with its high mortality rate attributed mainly to non-small cell lung cancer (NSCLC). Although immunotherapy with immune checkpoint inhibitors...
4.
Senan-Salinas A, Comas L, Esteban P, Garzon-Tituana M, Cheng Z, Santiago L, et al.
ACS Pharmacol Transl Sci
. 2024 May;
7(5):1474-1484.
PMID: 38751645
Granzymes (Gzms), a family of serine proteases, expressed by immune and nonimmune cells, present perforin-dependent and independent intracellular and extracellular functions. When released in the extracellular space, GzmA, with trypsin-like...
5.
Moratiel-Pellitero A, Zapata-Garcia M, Gascon-Ruiz M, Sesma A, Quilez E, Ramirez-Labrada A, et al.
Cancers (Basel)
. 2024 Mar;
16(6).
PMID: 38539479
Immune checkpoint inhibitors have been proposed as the standard treatment for different stages of non-small-cell lung cancer in multiple indications. Not all patients benefit from these treatments, however, and certain...
6.
Gascon-Ruiz M, Ramirez-Labrada A, Lastra R, Martinez-Lostao L, Pano-Pardo J, Sesma A, et al.
Cancers (Basel)
. 2023 Jan;
15(2).
PMID: 36672279
(1) Despite the effectiveness of immune checkpoint inhibitors (ICIs) in lung cancer, there is a lack of knowledge about predictive biomarkers. The objective of our study is to analyze different...
7.
Redrado S, Esteban P, Domingo M, Lopez C, Rezusta A, Ramirez-Labrada A, et al.
J Fungi (Basel)
. 2022 Apr;
8(4).
PMID: 35448592
Gliotoxin is a fungal secondary metabolite with impact on health and agriculture since it might act as virulence factor and contaminate human and animal food. Homologous gliotoxin (GT) gene clusters...
8.
Uranga-Murillo I, Tapia E, Garzon-Tituana M, Ramirez-Labrada A, Santiago L, Pesini C, et al.
Theranostics
. 2021 Nov;
11(20):9873-9883.
PMID: 34815792
Recent findings suggest that the serine protease Granzyme K (GzmK) may act as a proinflammatory mediator. However, its role in sepsis is unknown. Here we aim to understand the role...
9.
Esteban P, Redrado S, Comas L, Domingo M, Millan-Lou M, Seral C, et al.
Toxins (Basel)
. 2021 Jan;
13(2).
PMID: 33498622
Multidrug-resistant bacteria such as methicillin-resistant (MRSA) is one of the major causes of hospital-acquired and community infections and pose a challenge to the human health care system. Therefore, it is...
10.
Comas L, Polo E, Domingo M, Hernandez Y, Arias M, Esteban P, et al.
Materials (Basel)
. 2019 Apr;
12(7).
PMID: 30987007
Gliotoxin (GT), a secondary metabolite produced by Aspergillus molds, has been proposed as a potential anti-tumor agent. Here we have developed a nanoparticle approach to enhance delivery of GT in...